Your browser doesn't support javascript.
The Importance of Understanding the Stages of COVID-19 in Treatment and Trials.
Griffin, Daniel O; Brennan-Rieder, Denise; Ngo, Binh; Kory, Pierre; Confalonieri, Marco; Shapiro, Leland; Iglesias, Jose; Dube, Michael; Nanda, Neha; In, Gino K; Arkfeld, Daniel; Chaudhary, Preet; Campese, Vito M; Hanna, Diana L; Sawcer, David; Ehresmann, Glenn; Peng, David; Smorgorzewski, Miroslaw; Amstrong, April; Vinjevoll, Eivind H; Dasgupta, Rajkumar; Sattler, Fred R; Mussini, Cristina; Mitjà, Oriol; Soriano, Vicente; Peschanski, Nicolas; Hayem, Gilles; Piccirillo, Maria Carmela; Lobo-Ferreira, António; Rivero, Iraldo B; Hung, Ivan F H; Rendell, Marc; Ditmore, Stephen; Varon, Joseph; Marik, Paul.
  • Griffin DO; Department of Medicine, Division of Infectious Diseases, Columbia University, College of Physicians and Surgeons, New York, USA; Research and Development at United Health Group Minnetonka, Minnesota, USA; ProHealth NY Lake Success, New York, USA.
  • Brennan-Rieder D; CoronaTracker Community Research Group.
  • Ngo B; Keck School of Medicine, University of Southern California, California, USA.
  • Kory P; Pulmonary and Critical Care Medicine, Aurora St. Luke's Medical Center, Milwaukee, WI, USA.
  • Confalonieri M; Azienda Ospedaliero-Universitaria di Trieste, Trieste, Italy.
  • Shapiro L; Rocky Mountain Regional Veterans Affairs Medical Center in Aurora, CO and University of Colorado Anschutz Medical Campus in Aurora, CO, USA.
  • Iglesias J; Jersey Shore University Medical Center, Neptune NJ, Hackensack Meridian School of Medicine at Seton Hall, Hackensack University, NJ, USA.
  • Dube M; Keck School of Medicine, University of Southern California, California, USA.
  • Nanda N; Keck School of Medicine, University of Southern California, California, USA.
  • In GK; Keck School of Medicine, University of Southern California, California, USA.
  • Arkfeld D; Keck School of Medicine, University of Southern California, California, USA.
  • Chaudhary P; Keck School of Medicine, University of Southern California, California, USA.
  • Campese VM; Keck School of Medicine, University of Southern California, California, USA.
  • Hanna DL; Keck School of Medicine, University of Southern California, California, USA.
  • Sawcer D; Keck School of Medicine, University of Southern California, California, USA.
  • Ehresmann G; Keck School of Medicine, University of Southern California, California, USA.
  • Peng D; Keck School of Medicine, University of Southern California, California, USA.
  • Smorgorzewski M; Keck School of Medicine, University of Southern California, California, USA.
  • Amstrong A; Keck School of Medicine, University of Southern California, California, USA.
  • Vinjevoll EH; Volda Hospital HMR, Volda, Norway.
  • Dasgupta R; Keck School of Medicine, University of Southern California, California, USA.
  • Sattler FR; Keck School of Medicine, University of Southern California, California, USA.
  • Mussini C; University of Modena and Reggio Emilia, Modena, Italy.
  • Mitjà O; Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
  • Soriano V; UNIR Health Sciences School and Medical Center, Madrid, Spain.
  • Peschanski N; University Hospital of Rennes, Rennes, France.
  • Hayem G; Hôpital Paris Saint-Joseph, Paris, France.
  • Piccirillo MC; Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Napoli, Italy.
  • Lobo-Ferreira A; Unidade de Investigação Cardiovascular, Faculdade de Medicina da Universidade do Porto, Centro Hospitalar Universitário de São João, Porto, and Hospital Rainha Santa Isabel, Marco de Canaveses, Portugal.
  • Rivero IB; Department of Clinical Investigations, Center for Genetic Engineering and Biotechnology, Havana, Cuba.
  • Hung IFH; Ivan FN Hung, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong.
  • Rendell M; The Rose Salter Medical Research Foundation, Newport Coast, CA, USA.
  • Ditmore S; Parkchester Times.
  • Varon J; United Memorial Medical Center and United General Hospital, UT Health Science Center at Houston, University of Texas School of Medicine, Houston, Texas, USA, Baylor College of Medicine, UAT, UDEM, UABC, UNE, USON, UPAEP - Mexico, Caribbean Medical University.
  • Marik P; Eastern Virginia Medical School|, Department of Internal Medicine, Chief, Pulmonary and Critical Care Medicine, Norfolk, VA, USA.
AIDS Rev ; 23(1): 40-47, 2021 02 08.
Article in English | MEDLINE | ID: covidwho-1070036
ABSTRACT
COVID-19, caused by SARS-CoV-2, continues to be a major health problem since its first description in Wuhan, China, in December 2019. Multiple drugs have been tried to date in the treatment of COVID-19. Critical to treatment of COVID-19 and advancing therapeutics is an appreciation of the multiple stages of this disease and the importance of timing for investigation and use of various agents. We considered articles related to COVID-19 indexed on PubMed published January 1, 2020-November 15, 2020, and considered papers on the medRxiv preprint server. We identified relevant stages of COVID-19 including three periods pre-exposure, incubation, and detectable viral replication; and five phases the viral symptom phase, the early inflammatory phase, the secondary infection phase, the multisystem inflammatory phase, and the tail phase. This common terminology should serve as a framework to guide when COVID-19 therapeutics being studied or currently in use is likely to provide benefit rather than harm.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Clinical Trials as Topic / SARS-CoV-2 / COVID-19 Drug Treatment Type of study: Prognostic study / Randomized controlled trials / Reviews Topics: Long Covid Limits: Humans Language: English Journal: AIDS Rev Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2021 Document Type: Article Affiliation country: AIDSRev.200001261

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Clinical Trials as Topic / SARS-CoV-2 / COVID-19 Drug Treatment Type of study: Prognostic study / Randomized controlled trials / Reviews Topics: Long Covid Limits: Humans Language: English Journal: AIDS Rev Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2021 Document Type: Article Affiliation country: AIDSRev.200001261